Raia Drogasil S.A. (BVMF:RADL3)
Brazil · Delayed Price · Currency is BRL 17.76
-0.44 (-2.42%)
Jul 29, 2026, 5:05 PM GMT-3
Raia Drogasil Income Statement
Financials in millions BRL. Fiscal year is January - December.
Millions BRL. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 45,546 | 44,250 | 38,872 | 33,974 | 29,067 | 24,127 | |
Revenue Growth | 16.65% | 13.84% | 14.42% | 16.88% | 20.48% | 20.23% |
Cost of Revenue | 32,009 | 31,286 | 27,315 | 23,766 | 20,234 | 16,921 |
Gross Profit | 13,537 | 12,965 | 11,557 | 10,207 | 8,834 | 7,206 |
Selling, General & Admin | 10,667 | 10,290 | 9,198 | 8,193 | 7,056 | 5,879 |
Other Operating Expenses | 219.15 | - | - | -147.8 | -82.57 | - |
Operating Expenses | 10,887 | 10,290 | 9,198 | 8,045 | 6,973 | 5,879 |
Operating Income | 2,651 | 2,675 | 2,358 | 2,162 | 1,860 | 1,327 |
Interest Expense | -1,152 | -1,075 | -822.09 | -744.7 | -564.42 | -320.32 |
Interest & Investment Income | 0 | - | 0.02 | 0.04 | 28.29 | 9.58 |
Earnings From Equity Investments | 3.03 | 1.99 | 1.07 | -12.51 | -0.82 | -1.13 |
Other Non Operating Income (Expenses) | -187.87 | -220.23 | -111.05 | -119.14 | -109.98 | -68.47 |
EBT Excluding Unusual Items | 1,314 | 1,382 | 1,426 | 1,286 | 1,213 | 946.61 |
Merger & Restructuring Charges | 25.64 | - | - | 0.86 | -28.35 | -23.41 |
Gain (Loss) on Sale of Investments | -14.04 | -11.12 | -11.29 | -9.28 | -7.76 | - |
Asset Writedown | -23.26 | -29.51 | -9.72 | - | - | - |
Legal Settlements | 0.03 | 0.03 | -1.12 | -60.96 | 15.94 | 64.24 |
Other Unusual Items | 107.05 | 107.05 | 14.82 | - | - | -0.17 |
Pretax Income | 1,409 | 1,448 | 1,419 | 1,217 | 1,193 | 987.26 |
Income Tax Expense | 104.18 | 147.81 | 207.62 | 129.55 | 178.24 | 223.13 |
Earnings From Continuing Operations | 1,305 | 1,300 | 1,211 | 1,087 | 1,015 | 764.13 |
Minority Interest in Earnings | -2.27 | -3.38 | -11.51 | -32.17 | -18.86 | -12.2 |
Net Income | 1,292 | 1,297 | 1,200 | 1,055 | 996.11 | 751.93 |
Net Income to Common | 1,292 | 1,297 | 1,200 | 1,055 | 996.11 | 751.93 |
Net Income Growth | 9.85% | 8.08% | 13.73% | 5.91% | 32.47% | 55.22% |
Shares Outstanding (Basic) | 1,639 | 1,647 | 1,682 | 1,729 | 1,748 | 1,750 |
Shares Outstanding (Diluted) | 1,660 | 1,659 | 1,688 | 1,729 | 1,754 | 1,754 |
Shares Change | -1.47% | -1.75% | -2.37% | -1.43% | -0.01% | 0.02% |
EPS (Basic) | 0.79 | 0.79 | 0.71 | 0.61 | 0.57 | 0.43 |
EPS (Diluted) | 0.78 | 0.78 | 0.71 | 0.61 | 0.57 | 0.43 |
EPS Growth | 11.48% | 10.01% | 16.50% | 7.46% | 32.48% | 55.18% |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | 1,287 | 1,028 | 1,488 | 480.75 | 493.34 | 701.34 |
Free Cash Flow Per Share | 0.78 | 0.62 | 0.88 | 0.28 | 0.28 | 0.40 |
Dividend Per Share | 0.324 | 0.392 | - | 0.208 | - | - |
Dividend Growth | 379.59% | - | - | - | - | - |
Gross Margin | 29.72% | 29.30% | 29.73% | 30.04% | 30.39% | 29.87% |
Operating Margin | 5.82% | 6.04% | 6.07% | 6.37% | 6.40% | 5.50% |
Profit Margin | 2.84% | 2.93% | 3.09% | 3.10% | 3.43% | 3.12% |
Free Cash Flow Margin | 2.83% | 2.32% | 3.83% | 1.42% | 1.70% | 2.91% |
EBITDA | 3,517 | 3,523 | 3,065 | 2,815 | 2,466 | 1,890 |
EBITDA Margin | 7.72% | 7.96% | 7.88% | 8.29% | 8.48% | 7.83% |
D&A For EBITDA | 866.3 | 847.58 | 706.31 | 652.77 | 605.49 | 563.46 |
EBIT | 2,651 | 2,675 | 2,358 | 2,162 | 1,860 | 1,327 |
EBIT Margin | 5.82% | 6.04% | 6.07% | 6.37% | 6.40% | 5.50% |
Effective Tax Rate | 7.39% | 10.21% | 14.63% | 10.65% | 14.94% | 22.60% |